Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management – Abbott
Abbott announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous glucose monitoring (CGM) technology had better glucose outcomes than those using… read more.
